Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.69%29.57B | -2.85%125.67B | 11.81%30.08B | 2.85%129.36B | 7.32%37.3B | 6.56%33.98B | 3.40%31.18B | -7.16%26.9B | -0.89%125.77B | -6.55%34.76B |
| Cost of revenue | 1.36%25.14B | -6.57%102.33B | 5.11%24.8B | 8.12%109.52B | 7.54%30.57B | 16.67%28.85B | 8.74%26.5B | -0.73%23.6B | -5.93%101.3B | -9.01%28.43B |
| Gross profit | -16.05%4.43B | 17.63%23.34B | 59.76%5.28B | -18.93%19.85B | 6.32%6.73B | -28.32%5.13B | -19.06%4.68B | -36.55%3.3B | 27.29%24.48B | 6.37%6.33B |
| Operating expense | 2.54%2.86B | 5.23%10.31B | 10.06%2.79B | -3.34%9.8B | -16.82%2.68B | -0.80%2.35B | -4.49%2.24B | 14.80%2.54B | 15.50%10.13B | 27.47%3.22B |
| Operating profit | -36.93%1.57B | 29.72%13.04B | 224.12%2.49B | -29.94%10.05B | 30.22%4.06B | -41.92%2.78B | -28.97%2.44B | -74.41%767M | 37.18%14.35B | -9.16%3.11B |
| Net non-operating interest income (expenses) | -250.00%-21M | -415.38%-134M | -20.00%-6M | 87.19%-26M | 0 | -180.00%-28M | 109.59%7M | -25.00%-5M | -63.71%-203M | -13.73%-116M |
| Non-operating interest income | -33.33%2M | 9.52%23M | -50.00%3M | 40.00%21M | -25.00%3M | 150.00%5M | 40.00%7M | 50.00%6M | 36.36%15M | 33.33%4M |
| Non-operating interest expense | 155.56%23M | 68.09%79M | -18.18%9M | -7.84%47M | -36.84%12M | 166.67%24M | --0 | 37.50%11M | 45.71%51M | 58.33%19M |
| Total other finance cost | ---- | 609.09%78M | ---- | -93.41%11M | -98.02%2M | ---- | ---- | ---- | 67.00%167M | 8.60%101M |
| Net investment income | -96.92%20M | -55.75%446M | -2.26%650M | 148.89%1.01B | 1,053.13%305M | 83.33%-117M | -53.73%155M | -17.29%665M | -42.06%405M | -107.62%-32M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -86.77%61M | 0 | 723.21%461M | 0.00%-16M | 583.78%506M | 0 | -29M | 205.66%56M | -16M | |
| Income from associates and other participating interests | -32.86%47M | -107.53%-7M | 40.00%70M | -25.00%93M | -641.67%-89M | 100.00%64M | 58.14%68M | -18.03%50M | 14.81%124M | -271.43%-12M |
| Special income (charges) | 50.00%3M | 881.48%1.06B | 2M | -75.12%108M | -61.22%76M | -28.57%20M | -93.94%12M | 0 | 3,000.00%434M | 880.00%196M |
| Less:Other special charges | -50.00%-3M | -881.48%-1.06B | ---2M | 75.12%-108M | 61.22%-76M | 28.57%-20M | ---- | ---- | -3,000.00%-434M | -880.00%-196M |
| Other non-operating income (expenses) | -64.29%40M | -30.12%232M | 700.00%112M | 33.87%332M | 250.00%30M | 15.79%88M | 86.92%200M | -83.53%14M | -82.61%248M | 95.16%-20M |
| Income before tax | -49.92%1.66B | 22.18%14.7B | 126.59%3.32B | -21.93%12.03B | 40.10%4.36B | -22.63%3.32B | -28.77%2.89B | -63.01%1.46B | 23.00%15.41B | -7.40%3.12B |
| Income tax | -46.63%594M | 38.14%4.96B | 235.24%1.11B | -24.39%3.59B | 19.26%1.23B | -20.70%1.09B | -17.91%935M | -72.33%332M | 18.07%4.74B | -8.75%1.03B |
| Net income | -51.59%1.07B | 15.40%9.74B | 94.87%2.2B | -20.84%8.44B | 50.43%3.13B | -23.54%2.23B | -33.01%1.95B | -58.98%1.13B | 25.35%10.67B | -6.68%2.08B |
| Net income continuous operations | -51.59%1.07B | 15.40%9.74B | 94.69%2.2B | -20.83%8.44B | 50.43%3.13B | -23.54%2.23B | -33.01%1.95B | -58.95%1.13B | 25.33%10.67B | -6.72%2.08B |
| Noncontrolling interests | -48.48%-49M | -119.15%-9M | 28.26%-33M | 2.17%47M | 215.03%199M | -173.76%-104M | -140.00%-2M | -163.01%-46M | -54.90%46M | -765.38%-173M |
| Net income attributable to the company | -50.11%1.12B | 16.18%9.75B | 89.89%2.24B | -20.94%8.4B | 30.02%2.93B | -15.95%2.33B | -32.83%1.95B | -56.10%1.18B | 26.33%10.62B | 2.31%2.26B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -50.11%1.12B | 16.18%9.75B | 89.89%2.24B | -20.94%8.4B | 30.02%2.93B | -15.95%2.33B | -32.83%1.95B | -56.10%1.18B | 26.33%10.62B | 2.31%2.26B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -52.72%17.74 | 9.47%160.9367 | 81.93%37.52 | -21.02%147.0133 | 29.82%51.2933 | -15.94%40.8967 | -32.85%34.2 | -56.16%20.6233 | 26.19%186.1367 | 2.14%39.51 |
| Diluted earnings per share | -52.72%17.74 | 9.14%160.4033 | 81.93%37.52 | -21.04%146.97 | 27.67%50.4405 | -15.95%40.8912 | -32.86%34.1985 | -56.16%20.6233 | 26.19%186.1367 | 2.16%39.5069 |
| Dividend per share | 0 | 29.63%58.3333 | 0 | 12.50%45 | 12.50%45 | 0 | 0 | 0 | 20.00%40 | 20.00%40 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |